메뉴 건너뛰기





Volumn 3, Issue 3, 2003, Pages 257-259

Iressa®: First angiogenesis inhibitor approved for the treatment of advanced NSCLC
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CANCER VACCINE; DOCETAXEL; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR DERIVATIVE; ESTROGEN RECEPTOR; GEFITINIB; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO; PROTEIN KINASE C; RECOMBINANT ERYTHROPOIETIN; TAMOXIFEN; TELOMERASE INHIBITOR; ZOLEDRONIC ACID;

EID: 0038207110     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note
Times cited : (1)

References (0)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.